The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 18, 2018
Filed:
May. 12, 2017
Applicants:
Kangwon National University University-industry Cooperation Foundatoin, Gangwon-do, KR;
Amolifescience Co., Ltd., Seoul, KR;
Inventors:
Kwon-Soo Ha, Gangwon-do, KR;
Yeon-Ju Lee, Gangwon-do, KR;
Assignees:
Kangwon National University University-Industry Cooperation Foundation and, Gangwon, KR;
Amolifescience Co., Ltd., Seoul, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01); A61K 38/17 (2006.01); A61K 31/135 (2006.01); A61K 31/145 (2006.01); A61K 9/00 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 31/135 (2013.01); A61K 31/145 (2013.01); A61K 38/1709 (2013.01); G01N 33/5023 (2013.01); C12N 2310/14 (2013.01); C12N 2320/35 (2013.01);
Abstract
Disclosed are a pharmaceutical composition and a method for preventing or treating diabetic complications caused by vascular leakage, comprising a TGase2 inhibitor, and a method of screening a preventive or therapeutic agent for diabetic complications caused by vascular leakage.